alxn1830

·Code: SYNT001

alxn1830: developed by 1 company. Updated within the last hour.

Development Pipeline (1)

CompanyPhase
ALEXION PHARMACEUTICALS, INC. (ALXN)Phase 3

Get deeper analysis on alxn1830

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    alxn1830 — Drug Pipeline, Trials & FDA Status | BioSniper